Article Versions Notes

Frere C, Crichi B, Wahl C, Lesteven E, Connault J, Durant C, Rueda-Camino JA, Yannoutos A, Bensaoula O, Le Maignan C, et al. The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis. Journal of Clinical Medicine. 2022; 11(13):3729. https://doi.org/10.3390/jcm11133729

Frere, Corinne, Benjamin Crichi, Clémentine Wahl, Elodie Lesteven, Jérôme Connault, Cécile Durant, Jose Antonio Rueda-Camino, Alexandra Yannoutos, Okba Bensaoula, Christine Le Maignan, and et al. 2022. "The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis" Journal of Clinical Medicine 11, no. 13: 3729. https://doi.org/10.3390/jcm11133729

Frere, C., Crichi, B., Wahl, C., Lesteven, E., Connault, J., Durant, C., Rueda-Camino, J. A., Yannoutos, A., Bensaoula, O., Le Maignan, C., Marjanovic, Z., & Farge, D. (2022). The Ottawa Score Performs Poorly to Identify Cancer Patients at High Risk of Recurrent Venous Thromboembolism: Insights from the TROPIQUE Study and Updated Meta-Analysis. Journal of Clinical Medicine, 11(13), 3729. https://doi.org/10.3390/jcm11133729